Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Cigna Group Director's Dealing 2025

Mar 17, 2025

29918_dirs_2025-03-17_ae08d3f8-c040-4887-9f8f-0c788accf0aa.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cigna Group (CI)
CIK: 0001739940
Period of Report: 2025-03-14

Reporting Person: Granger Elder (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-03-14 Common Stock, $.01 Par Value M 2376.0000 $151.4786 Acquired 7847.0000 Direct
2025-03-14 Common Stock, $.01 Par Value S 2376.0000 $310.3500 Disposed 5471.0000 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2025-03-14 Employee Stock Option (Right to Buy) $151.4786 M 2376.0000 Disposed 2026-05-04 Common Stock, $.01 Par Value (2376.0000) Direct

Footnotes

F1: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2024.

F2: These stock options were granted on May 4, 2016 and were fully vested at the closing of the acquisition of Express Scripts Holding Company on December 20, 2018.